ALISO VIEJO, Calif: Metagenics, Inc., a health sciences company, announced today the release of Hemp Advantage Plus, the third formula launched this year in the Metagenics hemp line.
Hemp Advantage Plus combines an organic, broad-spectrum hemp extract with palmitoylethanolamide (PEA) in a patent-pending formula.
PEA is a naturally occurring compound found in lipid extracts of foods and plants, as well as in the body's organs and fluids. It has been clinically studied on more than 4,000 people worldwide for its safety and efficacy, and numerous studies have shown that PEA supports bodily comfort and increases subjective measures of quality of life.*
The phytocannabinoids and terpenes in hemp along with PEA may work synergistically to support endocannabinoid system (ECS) function and modulate balance in the body — providing greater benefits than any of these compounds alone, also known as the entourage effect.*
The endocannabinoid system is a rapidly growing area of interest for practitioners, patients, and researchers alike, shares Matthew Martinez, Metagenics General Manager of North America. By combining hemp with PEA, we're leveraging science on the endocannabinoid system and the entourage effect to offer an innovative, practitioner-exclusive formula.
Metagenics continues with its focus on transparency by including Hemp Advantage Plus in its TruQuality program, an initiative that provides practitioners and patients full access to analytical data from quality assurance tests performed on each lot of Metagenics products. Hemp Advantage Plus is glyphosate-tested; other tests are done for heavy metals, pesticides, solvent residues, environmental contaminants, and common allergens, including gluten.
For more information on Metagenics hemp formulas, visit Metagenics.com/hemp.
Find any Critical Errors? Please Report It!